My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1319

    1.

    Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

    Maggs DG, Buchanan TA, Burant CF, Cline G, Gumbiner B, Hsueh WA, Inzucchi S, Kelley D, Nolan J, Olefsky JM, Polonsky KS, Silver D, Valiquett TR, Shulman GI.

    Ann Intern Med. 1998 Feb 1;128(3):176-85.PMID: 9454525 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group.

    Fonseca VA, Valiquett TR, Huang SM, Ghazzi MN, Whitcomb RW.

    J Clin Endocrinol Metab. 1998 Sep;83(9):3169-76.PMID: 9745421 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.

    Kumar S, Boulton AJ, Beck-Nielsen H, Berthezene F, Muggeo M, Persson B, Spinas GA, Donoghue S, Lettis S, Stewart-Long P.

    Diabetologia. 1996 Jun;39(6):701-9. Erratum in: Diabetologia 1996 Oct;39(10):1245. PMID: 8781766 [PubMed - indexed for MEDLINE]Related articles

    4.

    The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.

    Yale JF, Valiquett TR, Ghazzi MN, Owens-Grillo JK, Whitcomb RW, Foyt HL.

    Ann Intern Med. 2001 May 1;134(9 Pt 1):737-45.PMID: 11329231 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.

    Frias JP, Yu JG, Kruszynska YT, Olefsky JM.

    Diabetes Care. 2000 Jan;23(1):64-9.PMID: 10857970 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.

    Kumar S, Prange A, Schulze J, Lettis S, Barnett AH.

    Diabet Med. 1998 Sep;15(9):772-9.PMID: 9737807 [PubMed - indexed for MEDLINE]Related articles

    7.

    A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.

    Yu JG, Kruszynska YT, Mulford MI, Olefsky JM.

    Diabetes. 1999 Dec;48(12):2414-21.PMID: 10580431 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

    Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA.

    Diabetes Care. 2001 Apr;24(4):710-9.PMID: 11315836 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

    Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI.

    N Engl J Med. 1998 Mar 26;338(13):867-72.PMID: 9516221 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes.

    Sironi AM, Vichi S, Gastaldelli A, Pecori N, Anichini R, Foot E, Seghieri G, Ferrannini E.

    Clin Pharmacol Ther. 1997 Aug;62(2):194-202.PMID: 9284856 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes.

    Mimura K, Umeda F, Hiramatsu S, Taniguchi S, Ono Y, Nakashima N, Kobayashi K, Masakado M, Sako Y, Nawata H.

    Diabet Med. 1994 Aug-Sep;11(7):685-91.PMID: 7955995 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.

    Kruszynska YT, Yu JG, Olefsky JM, Sobel BE.

    Diabetes. 2000 Apr;49(4):633-9.PMID: 10871202 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.

    Antonucci T, Whitcomb R, McLain R, Lockwood D, Norris RM.

    Diabetes Care. 1997 Feb;20(2):188-93. Erratum in: Diabetes Care 1998 Apr;21(4):678. PMID: 9118772 [PubMed - indexed for MEDLINE]Related articles

    14.

    Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

    Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J.

    N Engl J Med. 1994 Nov 3;331(18):1188-93.PMID: 7935656 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group.

    Horton ES, Whitehouse F, Ghazzi MN, Venable TC, Whitcomb RW.

    Diabetes Care. 1998 Sep;21(9):1462-9.PMID: 9727892 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

    Schwartz S, Raskin P, Fonseca V, Graveline JF.

    N Engl J Med. 1998 Mar 26;338(13):861-6.PMID: 9516220 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study Group.

    Buse JB, Gumbiner B, Mathias NP, Nelson DM, Faja BW, Whitcomb RW.

    Diabetes Care. 1998 Sep;21(9):1455-61.PMID: 9727891 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes.

    Ebeling P, Teppo AM, Koistinen HA, Viikari J, Rönnemaa T, Nissén M, Bergkulla S, Salmela P, Saltevo J, Koivisto VA.

    Diabetologia. 1999 Dec;42(12):1433-8.PMID: 10651262 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

    Fonseca V, Rosenstock J, Patwardhan R, Salzman A.

    JAMA. 2000 Apr 5;283(13):1695-702. Erratum in: JAMA 2000 Sep 20;284(11):1384. PMID: 10755495 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.

    Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T.

    Diabet Med. 1996 Apr;13(4):365-70.PMID: 9162613 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity